Medicure (MCUJF) Free Cash Flow Growth (5y) (2014 - 2026)
Medicure (MCUJF) Free Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.52 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.94% |
| Dec 31, 2025 | 15.16% |
| Sep 30, 2025 | -21.77% |
| Jun 30, 2025 | 5.56% |
| Mar 31, 2025 | 22.39% |
| Dec 31, 2024 | 20.84% |
| Sep 30, 2024 | 27.43% |
| Jun 30, 2024 | 64.54% |
| Mar 31, 2024 | 40.38% |
| Dec 31, 2023 | 19.31% |
| Sep 30, 2023 | -41.55% |
| Jun 30, 2023 | 17.09% |
| Mar 31, 2023 | -17.14% |
| Sep 30, 2022 | -46.17% |
| Jun 30, 2022 | 19.07% |
| Mar 31, 2022 | -10.01% |
| Sep 30, 2021 | 44.77% |
| Jun 30, 2021 | 29.79% |
| Mar 31, 2021 | -45.04% |
| Dec 31, 2020 | -28.89% |